Medicine expenditure in hospitals and Local Health Units (ULS) reached 1.6 billion euros by July. This value represents a significant increase compared to the same period in the previous year.
According to the data presented, the total value represents 70 million euros more than recorded in the same period of 2025. This growth in hospital pharmaceutical expenditure highlights the continuous pressure on health sector costs in Portugal.
The article does not specify which medicines contributed most to this increase nor which ULS recorded the highest spending. No government measures to control this growing expenditure are mentioned either.
This growth in medicine expenditure comes in a context of financial challenges for the National Health Service, which has been facing budgetary pressures in various areas.




